ArticleClinical and translational allergy2020

Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study.

Hanneke N G Oude Elberink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.